CD36 and Alzheimer disease: Although it seems contradictory on the role of CD36 in AD pathology, in general, AD therapeutic strategies targeting CD36 have focused on two aspects: 1) blocking CD36 using neutralizing antibodies or other small molecules to inhibit the inflammatory response of microglia, such as salvinorin B, tanshinone IIA, curcumin, and small molecule compounds (100).